BioMaxima Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
BioMaxima has a total shareholder equity of PLN46.6M and total debt of PLN11.5M, which brings its debt-to-equity ratio to 24.7%. Its total assets and total liabilities are PLN74.3M and PLN27.7M respectively.
Anahtar bilgiler
24.7%
Borç/özkaynak oranı
zł11.52m
Borç
Faiz karşılama oranı | n/a |
Nakit | zł1.00m |
Eşitlik | zł46.60m |
Toplam yükümlülükler | zł27.68m |
Toplam varlıklar | zł74.28m |
Son finansal sağlık güncellemeleri
BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt
Aug 22BioMaxima (WSE:BMX) Seems To Use Debt Quite Sensibly
Mar 07We Think BioMaxima (WSE:BMX) Can Stay On Top Of Its Debt
Jun 04Does BioMaxima (WSE:BMX) Have A Healthy Balance Sheet?
Feb 18Recent updates
BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt
Aug 22BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Jun 08BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Apr 21Returns On Capital Are Showing Encouraging Signs At BioMaxima (WSE:BMX)
Sep 07BioMaxima (WSE:BMX) Seems To Use Debt Quite Sensibly
Mar 07We Think BioMaxima (WSE:BMX) Might Have The DNA Of A Multi-Bagger
Feb 02BioMaxima (WSE:BMX) Knows How To Allocate Capital Effectively
Sep 06We Think BioMaxima (WSE:BMX) Can Stay On Top Of Its Debt
Jun 04Does BioMaxima (WSE:BMX) Have A Healthy Balance Sheet?
Feb 18Are BioMaxima's (WSE:BMX) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 14Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: BMX's short term assets (PLN23.6M) exceed its short term liabilities (PLN12.9M).
Uzun Vadeli Yükümlülükler: BMX's short term assets (PLN23.6M) exceed its long term liabilities (PLN14.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: BMX's net debt to equity ratio (22.6%) is considered satisfactory.
Borcun Azaltılması: BMX's debt to equity ratio has reduced from 86.6% to 24.7% over the past 5 years.
Borç Kapsamı: BMX's debt is well covered by operating cash flow (41.6%).
Faiz Kapsamı: Insufficient data to determine if BMX's interest payments on its debt are well covered by EBIT.